MS
Maxwell Skor Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
5
Avg Return
Past Year
Past Year
4.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $115 |
96%
upside
| 1 | -7.1% |
0
%
| 9 Jan ‘26 2 months ago |
|
|
|
Overweight
Initiated
| $190 | – | 1 | +110% |
0
%
| 16 Oct ‘25 4 months ago |
|
|
|
Equal-Weight
Maintained
| $144 |
1%
downside
| 1 | – |
–
| 21 Aug ‘25 6 months ago |
|
|
|
Overweight
Assumed
| $250 |
3%
upside
| 1 | +40% |
0
%
| 3 Jul ‘25 8 months ago |
|
|
|
Overweight
Assumed
| $12 |
258%
upside
| 1 | +16% |
0
%
| 3 Jul ‘25 8 months ago |
|
|
|
Overweight
Assumed
| $10 |
733%
upside
| 1 | -32% |
0
%
| 14 Mar ‘25 1 year ago |
|